SEARCH RESULTS FOR: "Tag: CBAY"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
CATEGORIES
Buzz Stocks(1)

6/11/2019 9:39 AM
The shares of Cymabay Therapeutics Inc (NASDAQ:CBAY) are plummeting, after its experimental drug used to treat a fatty liver disease called nonalcoholic steatohepatitis (NASH) was only minimally effec...
PEOPLE ALSO SEARCH FOR
 
Special Offers from Schaeffer's Trading Partners